Woodline Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Woodline Partners’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-210,337	Closed	-$19.5M	–	890
2021 Q4	$19.5M	Buy	210,337 +6,112	+3%	+$403K	0.28%	104
2021 Q3	$12.2M	Sell	204,225 -216,728	-51%	-$12.8M	0.2%	141
2021 Q2	$28.7M	Buy	+420,953	New	+$27.4M	0.54%	45

Woodline Partners's ARNA Position: Q1 2022 in Review

Woodline Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 210,337 shares — an estimated $19.5M sold.

Woodline Partners first reported a position in ARNA in Q2 2021 and held it in 3 quarters. The position peaked at $28.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Woodline Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Woodline Partners sold 210,337 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $19.5M.
Woodline Partners first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 3 quarters.
Woodline Partners's Arena Pharmaceuticals Inc position peaked at $28.7M in Q2 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.